Multiplexed imaging reveals an IFN-γ-driven inflammatory state in nivolumab-associated gastritis
Summary: Immune checkpoint blockade using PD-1 inhibition is an effective approach for treating a wide variety of cancer subtypes. While lower gastrointestinal (GI) side effects are more common, upper gastrointestinal adverse events are rarely reported. Here, we present a case of nivolumab-associate...
Main Authors: | Selena Ferrian, Candace C. Liu, Erin F. McCaffrey, Rashmi Kumar, Theodore S. Nowicki, David W. Dawson, Alex Baranski, John A. Glaspy, Antoni Ribas, Sean C. Bendall, Michael Angelo |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-10-01
|
Series: | Cell Reports Medicine |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2666379121002810 |
Similar Items
-
Severe Gastritis Due to Nivolumab Treatment of a Metastatic Melanoma Patient
by: George Samonis, et al.
Published: (2022-11-01) -
Severe Gastritis after Administration of Nivolumab and Ipilimumab
by: Yoshito Nishimura, et al.
Published: (2018-08-01) -
Changes in the salivary metabolome in patients with chronic erosive gastritis
by: Shaowei Liu, et al.
Published: (2023-05-01) -
Gastritis flemonosa difusa aguda
by: Alberto Valls, et al.
Published: (1976-02-01) -
Emphysematous gastritis
by: Ryosuke Takase, et al.
Published: (2021-11-01)